Use of M-M-R II outside of the routinely recommended age range – a systematic literature review
| Autor: | Barbara J. Kuter, Elvira Schmidt, Elizabeth Richardson, Jaime Fergie, Louise Parks Saldutti, Monika Neumann, Manjiri Pawaskar, Gary S. Marshall, Linnea Koller, Se Li |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Aged
80 and over Pharmacology Pediatrics medicine.medical_specialty business.industry Range (biology) Immunology Infant Antibodies Viral medicine.disease MMR vaccine Rubella Measles Systematic review medicine Humans Immunology and Allergy Vaccines Combined business Antigens Viral Mumps Immunization Schedule Measles-Mumps-Rubella Vaccine |
| Zdroj: | Human Vaccines & Immunotherapeutics. 18:1-7 |
| ISSN: | 2164-554X 2164-5515 |
| Popis: | M-M-R®II (M-M-R II) is routinely used in many countries at 12–15 months with a second dose at 4 to 6 years of age. However, the vaccine may need to be administered at other ages due to delays in th... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|